NEWS
![](https://oslocancercluster.no/wp-content/uploads/2023/03/IMG_5058-260x185.jpg)
Kantar: Few Norwegians know about clinical trials
Nearly 7 out of 10 Norwegians do not know about opportunities for clinical trials
![](https://oslocancercluster.no/wp-content/uploads/2023/03/IMG_20230310_104326-260x185.jpg)
Taking the leap for cancer research
Weyergang wants to make cancer treatment more effective
![](https://oslocancercluster.no/wp-content/uploads/2023/03/banner-g08d5b417d_1920-260x185.jpg)
EU wants more Comprehensive Cancer Centres
By 2030, EU wants 90% of eligible patients to have access to Comprehensive Cancer Centres.
![](https://oslocancercluster.no/wp-content/uploads/2023/03/oledahlberg_web-260x185.jpg)
Learning from the Americans
Interview with Ole Dahlberg, CEO of Curida Diatec
![](https://oslocancercluster.no/wp-content/uploads/2023/02/iStock-970394890-260x185.jpg)
More personalised breast cancer screening
Can a new genetic test improve breast cancer screening?
![](https://oslocancercluster.no/wp-content/uploads/2023/02/decgathering_newmembers-260x185.jpg)
Meet our newest members
Get to know the latest additions to our cancer cluster better!
![Two men and two women looking into the camera wearing dressed up clothes](https://oslocancercluster.no/wp-content/uploads/2023/02/Klyngeledere_foto_JofridAsland_NorwegianSmartCare-Cluster-260x185.png)
Klynger samarbeider om å styrke investor-arbeidet
Klyngene har en unik rolle i å øke private investeringer til norsk næringsliv.
![](https://oslocancercluster.no/wp-content/uploads/2023/02/CancerCrosslinks2023_topimage-260x185.jpg)
A leading Norwegian oncology arena
Cancer Crosslinks 2023 attracted more than 300 on-site participants.
![](https://oslocancercluster.no/wp-content/uploads/2023/01/OCC-Incubator-GU-Ventures-visit-260x185.jpg)
GU Ventures visited Oslo Cancer Cluster Incubator
New connections between Oslo and Gothenburg